YZYong Zhang

Yong Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yong Zhang has a total of 21 co-authors. Here are the top co-authors by number of shared publications:

  • Qiuling Shi

    School of Public Health, Chongqing Medical University, Chongqing, People’s Republic of China

    3 shared publications
  • Dan Kang

    School of Public Health, Chongqing Medical University, Chongqing, People’s Republic of China

    2 shared publications
  • Fang Liu

    Department of Integrated Traditional Chinese and Western Medicine, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, Sichuan, China

    2 shared publications
  • Qingsong Yu

    Chengdu Center for Disease Control and Prevention, Chengdu, Sichuan, People’s Republic of China

    2 shared publications
  • Yiding Dai

    Department of Integrated Traditional Chinese and Western Medicine, Sichuan Cancer Hospital & Institute, Chengdu, China

    2 shared publications
  • Bowei Huang

    Department of Integrated Traditional Chinese and Western Medicine, Sichuan Cancer Hospital & Institute, Chengdu, China

    1 shared publication

Latest Publications

  • Dual trajectories of patient-reported fatigue and sleep disturbance in lung cancer survivors

    by Jingjing Huang, Yong Zhang, Yiding Dai, Bowei Huang, Runjia He, Jie Luo, Yiwei Zeng, Fang Liu, Qiuling Shi

  • Open Access

    Who is Seeking Traditional Chinese Medicine (TCM) for Cancer? Insights from a Large Cohort in a Rehabilitation Clinic

    by Yong Zhang, Yiding Dai, Dan Kang, Qingsong Yu, Xiangxi Zhou, Xin Tian, Qiulong Chen, Yi Chen, Fang Liu, Qiuling Shi

    Purpose: Traditional Chinese Medicine (TCM) is widely used in cancer care, yet its utilization features are not well understood. By providing a comprehensive overview of the demographic and clinical characteristics, symptom burden, HRQoL, and TCM constitution of cancer patients seeking TCM treatment, we aim to offer insights into the integration of TCM into cancer care. Patients and Methods: The questionnaire collected data on demographic and clinical characteristics, the MD Anderson Symptom Inventory for Traditional Chinese Medicine (MDASI-TCM), the EuroQol-5Dimensions-5Levels (EQ-5D-5L), and the simplified version of the Constitution in Chinese Medicine Questionnaire (CCMQ). A descriptive analysis was conducted to profile the patients’ status and expectations of TCM. Chi-square or Fisher exact tests were employed to compare the distribution of TCM constitutional types across different cancer diagnoses. Results: Among 3047 eligible patients, 2796 (median age 55) completed the questionnaire and were subsequently included in the analysis. The cohort was predominantly female (56.5%), with lung cancer being the most common primary diagnosis (25.2%). Furthermore, 86.7% of the patients presented with a good performance status (ECOG-PS ≤ 1). The main reasons patients sought TCM treatment were to alleviate cancer-related symptoms (59.4%) and enhance immune function (55.4%). The most prevalent symptoms (scored 1– 10 on a 0– 10 scale) were fatigue (81.1%), followed by disturbed sleep (81.0%), and dry mouth (78.2%). The mean and median EQ-5D-5L utility scores were 0.81 and 0.89, respectively. About 83.4% of cancer patients exhibited a deviation in TCM constitution, with Yang-deficiency being particularly common among them. Conclusion: This study highlights the symptom burden, HRQoL, TCM constitution, and characteristics of patients who pursue TCM treatment. It advances our understanding of TCM’s role in cancer rehabilitation by shedding light on target population potential needs of care. The findings provide a foundation for developing evidence-based strategies to enhance TCM application in clinical settings, optimize resource allocation, and improve rehabilitation outcomes for cancer patients.


  • Open Access

    Shortness of breath on the day of discharge: an early alert for post-discharge complications in patients undergoing lung cancer surgery

    by Dan Kang, Cheng Lei, Yong Zhang, Xing Wei, Wei Dai, Wei Xu, Jingyu Zhang, Qingsong Yu, Xueyao Su, Yanyan Huang, et al.

    Purpose: Symptom assessment based on patient-reported outcome (PRO) can correlate with disease severity, making it a potential tool for threshold alerts of postoperative complications. This study aimed to determine whether shortness of breath (SOB) scores on the day of discharge could predict the development of post-discharge complications in patients who underwent lung cancer surgery. Methods: Patients were from a study of a dynamic perioperative rehabilitation cohort of lung cancer patients focusing on patient-reported outcomes. Patients were assessed using the Perioperative Symptom Assessment Scale for Lung surgery (PSA-Lung). Logistic regression model was used to examine the potential association between SOB on the day of discharge and complications within 3 months after discharge. The post-discharge complications were taken as the anchor variable to determine the optimal cutpoint for SOB on the day of discharge. Results: Complications within 3 months post-discharge occurred in 71 (10.84%) of 655 patients. Logistic regression analysis revealed that being female (OR 1.764, 95% CI 1.006–3.092, P < 0.05) and having two chest tubes (OR 2.026, 95% CI 1.107–3.710, P < 0.05) were significantly associated with post-discharge complications. Additionally, the SOB score on the day of discharge (OR 1.125, 95% CI 1.012–1.250, P < 0.05) was a significant predictor. The optimal SOB cutpoint was 5 (on a scale of 0–10). Patients with an SOB score ≥ 5 at discharge experienced a lower quality of life 1 month later compared to those with SOB scoreP < 0.05). Conclusion: SOB on the day of discharge may serve as an early warning sign for the timely detection of 3 month post-discharge complications.